Surface Oncology, Inc. (SURF) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
09M18M26M35M44M52M61M70MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Operating Expenses

Research And Development ExpensesGeneral And Administrative ExpensesOther Expenses
04M8M11M15M19M22M26M30MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

EBITDA

EBITDA
-40M-35M-30M-25M-20M-15M-10M-5M1Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

EPS

Revenue Variation (%)

Revenue Variation
-200-175-150-125-100-74-49-241Q2 2022Q1 2023

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
01020304050607080Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Revenue YoY Variation (%)

Revenue YoY Variation
-2004K7K11K15K19K22K26K30KQ2 2022Q3 2022Q4 2022Q1 2023

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
04K8K11K15K19K22K26K30KQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Price-to-Earning Ratio

P/E Ratio
-1-1-0-000011Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Income Breakdown

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000001111Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q2 2022Q3 2022Q4 2022Q1 2023Q2 2023
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
02M5M8M10M12M15M18M20MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Free Cash Flow

Cash At End Of Period
011M22M34M45M56M68M79M90MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
02M5M8M10M12M15M18M20MQ2 2022Q3 2022Q4 2022Q1 2023Q2 2023
🏦 Balance Sheet
📈 Key Metrics